Adrenal atrophy pathophysiology: Difference between revisions

Jump to navigation Jump to search
Line 5: Line 5:
==Pathophysiology==
==Pathophysiology==


[[Image:adrenalatrophy123456.jpg|left|thumbnail|Adrenal Atrophy; source: U.S. National Toxicology Program - available at:https://ntp.niehs.nih.gov/nnl/endocrine/adrenal/cxzatrophy/index.htm]]
[[Image:adrenalatrophy123456.jpg|left|thumbnail|Adrenal Atrophy; source: U.S. National Toxicology Program - available at: https://ntp.niehs.nih.gov/nnl/endocrine/adrenal/cxzatrophy/index.htm]]


===Primary adrenal insufficiency===
===Primary adrenal insufficiency===

Revision as of 19:35, 30 December 2021

Adrenal atrophy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adrenal atrophy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Adrenal atrophy pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adrenal atrophy pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adrenal atrophy pathophysiology

CDC on Adrenal atrophy pathophysiology

Adrenal atrophy pathophysiology in the news

Blogs on Adrenal atrophy pathophysiology

Directions to Hospitals Treating Adrenal atrophy

Risk calculators and risk factors for Adrenal atrophy pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Pathophysiology

Adrenal Atrophy; source: U.S. National Toxicology Program - available at: https://ntp.niehs.nih.gov/nnl/endocrine/adrenal/cxzatrophy/index.htm

Primary adrenal insufficiency

Primary adrenal insufficiency, which can be acute or chronic, may be caused by the anatomic destruction of the gland. This destruction can have various causes, including tuberculosis (TB) or fungal infection, other diseases infiltrating the adrenal glands, and hemorrhage. However, the most frequent cause is idiopathic atrophy, which is probably autoimmune in origin.

Primary adrenal insufficiency also may be caused by metabolic failure (eg, insufficient hormone production). This failure may be a result of congenital adrenal hyperplasia, enzyme inhibitors (e.g., metyrapone), or cytotoxic agents (e.g., mitotane).

Primary adrenocortical insufficiency is rare and it occurs at any age. The male-to-female ratio is 1:1.

Secondary adrenal insufficiency

Secondary adrenal insufficiency may be caused by hypopituitarism due to hypothalamic-pituitary disease, or it may result from suppression of the hypothalamic-pituitary axis by exogenous steroids or endogenous steroids (i.e., tumor).

Secondary adrenocortical insufficiency is relatively common. Extensive therapeutic use of steroids has greatly contributed to increased incidence.

Acute adrenocortical insufficiency

Adrenal crisis may result from an acute exacerbation of chronic insufficiency, usually caused by sepsis or surgical stress. Acute adrenal insufficiency also can be caused by adrenal hemorrhage (e.g., usually septicemia-induced Waterhouse-Friderichsen syndrome - fulminant meningococcemia) and anticoagulation complications.

Steroid withdrawal is the most common cause of acute adrenocortical insufficiency, and it almost exclusively causes a glucocorticoid deficiency.

References

Template:WH Template:WS